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Polyphenols have been shown to exhibit anti-viral activity in vitro, making them a 
promising starting point for the development of HIV treatment drugs. The main 
objective of this thesis was to assess the inhibitory effect of polyphenols extracted from 
Myrothamnus flabellifolia (Welw.) on M-MLV and HIV-I reverse transcriptases. The 
first part of the thesis was an attempt to isolate 3,4,5 tri-O-galloylquinic acid, the major 
polyphenol found in Namibian Myrothamnus flabellifolia plants. This polyphenol was 
successfully purified by column chromatography (Sephadex LH-20) and its purity was 
confirmed by HPLC and MALDI-TOF mass spectrometry. The second part of this thesis 
involved the development of a polymerase enzyme activity assay based on ethidium 
bromide fluorescence. A calibration curve for quantification of DNA was therefore 
prepared from the ethidium bromide fluorescence of Calf Thymus DNA. Results 
demonstrated that Calf Thymus DNA was a good standard for estimating the amount of 
cDNA synthesised during reverse transcription, thus enabling the monitoring of both 
M-ML V and HIV -I reverse transcriptase activity. The reverse transcriptase activity assay 
was optimised using a poly (rA) template, an oligo (dTb primer and dTTP as a 
substrate. It was observed that the rate of catalysis for M-ML V and HIV -I RTs decreased 
with increase in the concentration of dTTP, which suggested substrate inhibition. A 
decrease in M-MLV RT activity with increased substrate concentration was found to be 
due to depletion of Mg2+ ions by dTTP. True substrate inhibition was however observed 
for HIV-I RT, and analysis of the observed kinetics suggested the formation of an 












HIV -I reverse transcriptase. A Hill coefficient of one was obtained at low dTTP 
concentration and less than one at high dTTP concentration, suggesting zero and negative 
cooperativity respectively. The final part of this thesis tested the inhibitory effect of pure 
and crude polyphenol fractions on the activity of M-MLV and HIV-I RTs. Results 
showed that all polyphenol fractions inhibited M-ML V and HIV -I reverse transcriptase 
activity, with the highest inhibitory activity demonstrated by the fraction that contained 
pure 3,4,5 tri-O-galloylquinic acid. The 50 % inhibitory concentrations of 
3,4,5 tri-O-galloylquinic acid was 0.5 f..lM for M-MLV RT and 34 f..lM for HIV-I RT. 
Lineweaver-Burk plots showed that 3,4,5 tri-O-galloylquinic acid inhibited both enzymes 
non-competitively. Pure non-competitive inhibition was observed for M-MLV RT and 
mixed non-competitive inhibition for HIV-I RT. Results showed that the binding of 
3,4,5 tri-O-galloylquinic acid to M-MLV RT was irreversible, suggesting strong binding 
under the conditions tested. 3,4,5 Tri-O-galloylquinic acid, however, bound to HIV-I RT 
reversibly. A comparison of catalytic efficiencies showed that M-MLV RT was more 
efficient than HIV -I RT under saturating substrate concentrations with Kcat (min-I) values 
of II ± 3 and 1.31 ± 0.02 respectively. M-MLV RT and HIV-I RT were, however, 
equally efficient under limiting substrate concentrations with Kcat/Km (min-
1M- I) values 













1.1 The Plant Myrolhamnu .• flabellij{}fia 
GcnoroiintTodoction 
JlyrOlhamn{}., flabelf!fi>lia (M flabellifi'lia) is a woody ~,urrection plant thal ,urviv~s 
long spdls of drought during \\hich it 10>l:s '15 'Yo of its "atcr coment and r~tains most of 
its chlorophyll. It grows in various regions of sOllthern Africa wher~ it grows on shallow 
soils and rocky outcrops (Figure 1.1). It has an extensi'e root net\\or\; system that 
p"ndrat~' ro<:k c~,it~" thll' making use of waler trapp"d during rain) ,~a"m 
(Sh~rv .. in d al.. 1\1<)8, Vilj"",n et al.. 2002, Moore ~t aI., 2(07). 
FI~urc L 1, Il .. k<ucd 11.f1.hellif~/ia pl."l. ~ro .. ln~ 0" r"<~y orco I" \'amibla 
Thi, plant has b<;~n ~polt~d to d~h~drate its leaves to an air dried ,tat~, <:ausing the 
Ica'~> to fold in such a wa~ changing th~ original gre~n col(lur (If th~ plant to hrown. 
This condition i, term~d anhydrobiosis and ha, man~ ddrim~ntal dfcC1S >llCh as 
irr~,' er,ible dam~ge to lipids, proteins, nucl~ic acids "-, Ilell a, the generation of reactive 
ox~g~n s)X'cie> (Krann~r et al .. 2(1()2). Unlike most plants, .11. flabdlifi>lia i, ~ble to 










Chapt .. I 
Thus M f/ahellifi,/ia has the abilily 10 maintain ils ph}siologicaJ slate under 
~nhydrobi"tic conditi(lns as well as reCCI'er fwm the damage induced during lransilion 
from a desiccaloo to a rehydrated SlalC. M jlabt'lIifi,/ia has been reported to remin a 
,igl1ilicul1t amount (If chlorophyll in the dri~d 'tate \~hich enables it to rapidl)' reC()~~r 
once it is rchydral~J (Kranncr ~1 aL. 2(02). Plants which arC able [0 rc~ivc from their 
desiccatioll slate arc commonly kno\\11 as dcsiccmilln tokrant ar resurrection plants 
tV icre et aL 2003). 
• 
1.2 Mt'dicinal use of M. j1abem{o/ill 
JI flabe/liji,/ia has a long hi,lor)' of uSC as a medicinal plant. It has bc~n used to treat 
coughs. abd(lmil1al pains, kidl1~y diw,ders as well as to sWrili/c wounus 
(Moore et ai .. 2(07), Smoh from the burnt plant directed into the vagina ha., b~en ,,,ed 
10 treat lIterine pain. Lea\'es have also been reported to treat gingivitis when che\\ed 











Chapter 1 General Introduction 
1.3 Constituents of M. flabellifolia 
The leaves of M flabellifolia have been reported to contain essential oils such as 
camphor and eucalyptol (Van Wyk and Gericke, 2000). These essential oils are thought 
to playa role in the healing properties of this plant (Viljoen et aI., 2002). Recent studies 
have also shown that M flabellifolia leaves contain a substantial amount of polyphenols 
(40 % by dry weight), the composition of which varied among plant samples from 
different geographical locations. The phenolics of Namibian plants, for instance, were 
shown to consist mainly of 3,4,5-tri-O-galloylquinic acid (Figure 1.7) whereas South 
African plant phenolics consisted of 3,4,5-tri-O-galloylquinic acid as well as higher 
molecular weight galloylquinic acids (Moore et aI., 2005a, 2005b). Current research has 
focused on understanding the role that these polyphenols play in desiccation tolerance as 
well as on the healing properties of this plant 
1.4 Polyphenols and their chemistry 
Polyphenols are secondary metabolites found in the leaves and other parts of higher 
plants, and they usually consist of at least one aromatic ring with one or more hydroxyl 
groups and other substituents. Polyphenols are classified into several groups including 
amongst others the tlavonoids and tannins (Baxter et aI., 1997, Bennick, 2002). 
1.4.1 Flavonoids 
Flavonoids are one of the largest and most diverse groups of polyphenols. They are based 
on a heterocyclic ring structure that is synthesized from phenylalanine and polyketide 











Chapter 1 General Introduction 
3-desoxyflavonoids (e.g. Flavone) and 3-hydroxyflavonoids (e.g. Flavonol) (Figure 1.3) 
(Bennick et aI., 2002). 
~ ~ 





A B C 
Figure 1.3: Structures of a basic flavonoid molecule (A) and two flavonoid branches: 
3-desoxyflavonoid (8) and 3-hydroxyflavonoid (C) 
1.4.2 Tannins 
Tannins are plant polyphenolic secondary metabolites having molecular weights larger 
than 500 daltons, and are well known for their ability to precipitate proteins. Two classes 
of tannins are known: the condensed and the hydrolysable tannins 
(Bennick et aI., 2002, Hagerman, 2002). 
1.4.3 Condensed Tannins 
Condensed tannins are formed by the polymerization of flavonoids through the formation 
of a covalent bond between the C-8 or C-6 of the terminal compound and 











Chapter I General Introduction 
Figure 1.4: Basic structure of condensed tannins 
The structure shows C8-C4 linkages and n can be equal to or above zero 
Condensed tannins normally undergo oxidative cleavage In hot alcohols 
(acid butanol reaction) to produce an unchanged terminal unit and anthocyanidin 
pigments (Figure 1.5) from extender compounds. Thus condensed tannins are often called 

















Chapter 1 General Introduction 
1.4.4 Hydrolysable Tannins 
Hydrolysable tannins are composed of a polyhydric alcohol, e.g. glucose or quinic acid, 
which is esterified to gallic acid or its dimer, hexahydroxydiphenic acid 
(Bennick, 2002, Makkar, 2003). Polymeric hydrolysable tannins are produced through 
oxidative cross-linkages or esterification of galloyl groups to other galloyl groups, 
resulting in the formation of depside bonds (Figure 1.6). Oepside bonds are ester bonds 
that involve a phenolic hydroxyl rather than an aliphatic hydroxyl group 









OH G /0 




Figure 1.6: Basic structure of a hydroJysabJe tannin showing meta-depside (A) and ester (B) bonds 
Examples of hydrolysable tannins include 3,4,5 tri-O-galloylquinic acid, which has been 
reported as the major polyphenol in the leaves of Namibian M flabellifolia plants 
(Moore et ai., 2005b). In this compound, galloyl groups form ester bonds with the 
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Figure 1.7: Structure of 3,4,5 tri-O-galloyIquinic acid. 











Chapter I General Introduction 
1.5 Biological functions of polyphenols 
1.5.1 Role of polyphenols in plants 
Polyphenols in plants are thought to protect against herbivores, act as antibiotics and 
protect against oxidative damage (Bennick et aI., 2002). In this latter role, they are 
thought to not only chelate metal ions, thereby preventing metal ion-catalysed formation 
of free radicals but also to donate electrons to neutralize such radicals (Hagerman, 2002). 
Their anti-herbivorous activity is thought to be due to precipitation of salivary proteins 
which limits digestibility and results in an astringent taste, thus making the plant 
unpalatable (Bennick et aI., 2002). Recently, polyphenols have also been proposed to 
protect plants from desiccation by maintaining the integrity of biological membranes, 
since they were able to protect the structural integrity ofliposomes (artificial membranes) 
subjected to dehydration and subsequent rehydration (Moore et aI., 2005b). 
1.5.2 Role of polyphenols in human health 
Consumption of foods that are rich in polyphenols has been associated with prevention of 
disease (Scalbert and Williamson, 2000). Widely published are the health benefits of 
consuming tea and red wine, both containing high concentrations of polyphenols 
(Rein et aI., 2000, Khan and Mukhtar, 2007). Flavonoids, for instance, are able to donate 
electrons which neutralize reactive oxygen species such as superoxide anions, hydroxyl 
radicals and lipid peroxy radicals. These radicals oxidize low density lipoproteins (LDL) 
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enhances platelet aggregation which is crucial in the development of diseases such as 
stroke (Rein et aI., 2000). 
1.5.3 The Polyphenol- Protein interaction 
Polyphenols, particularly tannins, are well known for their ability to interact with proteins 
through hydrophobic as well as hydrogen bonding interactions. Hydrophobic interactions 
are thought to occur through the interaction between the galloyl ring of the polyphenol 
and the pyrrolidine ring face in the proteins (Murray et aI., 1994). Hydrogen bonding, 
on the other hand, occurs through the interaction between the hydroxyl 
groups of the polyphenol with the peptide carbonyl group, which is strengthened 
by the alkyl substitution on the amide nitrogen adjacent to the carbonyl. 
This carbonyl group acts as a strong hydrogen bond acceptor 
(Hagerman and Butler, 1981). Polyphenols and protein interactions have been proposed 
to undergo a two step mechanism. Initially, polyphenols form soluble non covalent 
complexes with proteins. Further addition of polyphenols cross-links the peptides 
resulting in an insoluble complex (Charlton et aI., 2002). Thus the molar ratio of tannin to 
protein seems to determine the solubility of the complex that is formed. In the 
gastrointestinal tract, where proteins are in excess, soluble complexes predominate. 
The precipitation process can be reversible or irreversible depending on the conditions 
under which complexation occurs. The reversibility is tested by treating the precipitate 
with protein denaturants such as SDS. SDS has been reported to solubilise the precipitate 
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favours the formation of stable covalent linkages within the polyphenol-protein complex 
which are resistant to denaturation (Chen and Hagerman, 2004). 
Since proteins form a major part of most biochemical processes, the presence of tannins 
would affect these processes. It has been reported that protein digestibility is reduced in 
tannin rich foods due to the fact that tannins bind to digestive enzymes and the dietary 
proteins (Carbonaro et aI., 1996). Polyphenols have also been reported to inhibit HIV 
reverse transcriptase, an enzyme that catalyses synthesis of cDNA from viral RNA 
(Nishizawa et aI., 1989, Bokesh et aI., 1996). Polyphenols also interfered with the in vitro 
production of plant cDNA via reverse transcriptase and the PCR amplification of DNA 











Chapter I General Introduction 
1.6 Reverse Transcriptase 
Reverse transcriptases belong to a DNA polymerase super family and play an important 
role in the retroviral life cycle (Das and Georgiadis, 2004). Retroviruses are 
multifunctional enzymes possessing both the RNA- and DNA- dependent polymerase and 
RNase H activities. The polymerase activity is responsible for the conversion of the 
single stranded RNA/DNA genome into double stranded DNA. The function of RNase H 
is to degrade the RNA strand of the RNA-DNA hybrid which is an intermediate in the 
retroviral replication process (Telesnitsky and Goff, 1993). In vivo, reverse transcription 
is initiated by the binding of tRNA to the primer binding site of the template, a process 
which is reportedly characterized by virus-specific interactions (Lanchy et ai., 1996). 
Reverse transcriptases have five domains: fingers, palm, thumb, connection and RNase 
H. The overall shape of these domains is thought to resemble the shape of the right hand, 
hence the nomenclature (Das and Georgiadis, 2004). The DNA and RNase H catalytic 
sites lie in separate domains which are linked within the same polypeptide 
(Telesnitsky and Goff, 1993). Specific examples of enzymes in the RT DNA polymerase 
super family include the M-ML V and HIV -1 reverse transcriptases. M-MLV RT has a 
number of important applications in molecular biology such as cDNA synthesis due to its 
relative low cost. HIV-l RT is an important enzyme in the life cycle of HIV infection 
(Figure 1.8) as it is responsible for converting a single stranded viral RNA to cDNA, 
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Chapter I General Introduction 
1.6.1 M-MLV and HIV-l RT Crystal Structures 
Although RT enzymes exhibit similar catalytic functions, their structures are reported to 
be very different (Fig 1.9-10). All enzymes in the RT super family are monomeric except 
for HIV-l RT which is heterodimeric (Oas and Georgiadis, 2004). M-MLV RT consists 
of 671 amino acid residues with a molecular weight of approximately 75 kOa, and has all 
five domains located on its single sub-unit. HIV -1 RT has two subunits, p66 and pSI, 
with molecular weights of 66 and 51 kOa respectively. These two subunits have four 
domains in common; the fifth, RNase H domain, is located on the p66 sub-unit. The 
polymerase activity of HIV -1 RT is located on the p66 subunit. (Huang et aI., 1998). 
1.6.2 M-MLV and HIV-l RT p66sub-unit 
A comparison of the crystal structure for M-ML V and HIV -1 RT p66 using the highly 
conserved region in the palm domain highlights some important similarities and 
differences. The important similarity is that all five domains that are present on the 
M-MLV RT enzyme (Figure 1.9A) are located on the HIV-I RT p66 subunit. A notable 
difference is that rotation angles of 18° and 70° relative to the M-ML V RT active site 
were required to overlay the thumb and the connection domains of M-MLV RT 
respectively onto similar domains on the HIV-I RT p66 sub-unit (Figure 1.98) 
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Figuro 1.10; An owrloy of<I")'''al 'l,udure< of the thunlh dOnloin (AI and tho <onnonion dOnl.in (8) 
for 't-~IL , . anti III \' -1 Kh W., anti (;rorliadi" W04) 
Ihe connection domains for both M-MLV and HIV-I RI are also reponed 10 have 
similar folding pattems. but Iltled poorly "h~n oY~rlaid (Figure I lOB). It ha~ also been 
reported that the connection domain is linked dir~'\:tly to the RNase II domain in 
HIV -I RT. wh~r~as in M-ML V RT Ihe polypeptide Ihat links Ihe tllO domains proceeds 
tn the opposite direction and has an additional 32 ammo acid residues 
(Das and Georgiadis. 20(4). 
1_6.4 I\I-J\.I L V and HIV -1 RT sl'tJuence alignment 
S~'<luence alignments demonstrak--d that secondal) structures in the two enzymes occur at 
similar positions, although Ihe:> dilTer in length (Figure 1.11). There is also greater 
sequence idenlily for the ftngers and palm domains than for the connection and RNase II 
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in Ih~ thumh domain and residues 473 ~504 bel\'l 'e~n the conn~cti()n and R:-Ias" H 
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Chapter 1 General Introduction 
1. 7 General mechanism of the polymerase reaction 
There are a senes of steps involved in the incorporation of dNTPs into the primer-
template complex by DNA polymerases. Initially, the enzyme is thought to form a binary 
complex with the primer-template complex in an open conformation state. This open 
state allows further binding of the complementary dNTPs downstream of the 31 - terminal 
primer nucleotide resulting in the formation of an open ternary complex. At this point the 
open ternary complex is changed to a closed ternary complex, which ensures 
coordination between the 3/-oxygen atom and the a-phosphorous of the dNTP through 
deprotonation. When the chemical reaction is complete, the enzyme completes its cycle 
of conformational changes by going back to an open state so as to allow release of 
pyrophosphate and to continue with the next dNTP incorporation 
(Yang et ai., 2004, Oelschlaeger et ai., 2007). 
1. 7.1 The role of magnesium ions in polymerization reaction 
The mechanism of the polymerase reaction has been reported to occur through the 
involvement of two metal ions, and in the case of reverse transcriptase, two divalent 
magnesium ions (Yang et ai., 2004). The first magnesium ion is bound to the nucleotide 
a-, p-, and y-phosphate oxygen atoms and is brought into the enzyme active site by the 
incoming complementary dNTP. This ion is also thought to facilitate the release of 
pyrophosphate from the active site (Yang et ai., 2004, Goldschmidt et ai., 2006). The 
second magnesium ion has been reported to bind to the three catalytic aspartate residues 
and the a- phosphate of the incoming dNTP (Goldschmidt et ai., 2006). This 
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u- phosphate or the dl\TP (Yang et al.. 2(04). A cr}stal structure of the HIV-I RT 
catal}lic complcl\. bound to the templateiprim~r compl"" and ddNTP has k~n repNled 
(Figur~ I. 12A). The SlruClure or the ""live sit~ i8 shown in Figure 1.12K Thi-; s/ruclure 
dearly ,ho\\5 the positions of the tv.o Mg'+ ions. emphasizing the importanc~ of M~'+ 
ions in the poi}merizmion r~oclion (Huang cI al.. 1999). 
B 
rigun l.ll: Th. ~.n.,"1 . !rudur. 111\'·1 RT e.ul)tic compl .. (A) .nd il> ~e'i ... ,it< (BI 
(Hung .. "I .. 1998). 
The gene,.1 ,true'",e 1..1.1 ,how, the pr,(, ,LJbunit ill eolouT and the pj I <ub"ni, in gro) The DKA ,ompl . 1< 
,n',nd i, ,t.",," ill gr •• n. Iii< .'ti,. ,it. (1)) ;h,,,,, tho b.d,~ro u"d "flh. d"IP pock., f,.,mod by ,he 
fingo", palrn and lhurnb <lornain, in an apf'IT'pTi.te ""nformaLion, The enLyme ,urface i, ,"""n in red foc 
negati,'e and hlue for I'<" iti,,· dcctrmto.tlo potollti,I,_ Tll< primor, t. mpl.t. and dN j P aT. OIl "io~ 










Chapter I General Introduction 
1.8 Enzyme Inhibition 
Enzyme inhibition refers to a reduction in the activity of an enzyme in the presence of 
other compounds. Knowledge of enzyme inhibition is crucial to the understanding of 
enzyme specificity as well as metabolic pathways (Whiteley, 2000). Enzyme inhibition 
is divided into two major classes, namely reversible and irreversible inhibition. 
Reversible inhibition is temporary and involves weak non-covalent interactions between 
the inhibitor and the enzyme. Irreversible inhibition is permanent and involves strong 
covalent interactions between the inhibitor and key amino acid residues of the enzyme, 
consequently decreasing the effective enzyme concentration (Garrett and Grisham, 2005). 
Further classification of enzyme inhibition is based on whether the inhibitor binds the 
enzyme at an active site or allosterically. Inhibition is competitive if the inhibitor binds 
to the active site and competes with the substrate, i.e. the inhibitor binds to the free 
enzyme only and its kinetics reveal an increase in Km and no change in maximal velocity 
(V max) values. In other cases, the inhibitor binds to a site on the enzyme other than the 
active site, in which case it is able to bind both the free enzyme and the enzyme substrate 
(ES) complex. This is known as non-competitive inhibition because the enzyme does not 
compete with the enzyme for binding to the active site. The Km remains unchanged but 
the maximum enzyme velocity (V max) is reduced. Finally, some inhibitors bind to the 
enzyme substrate (ES) complex only. This is known as un-competitive inhibition and the 











Chapter 1 General Introduction 
1.8.1 The role of enzyme inhibition in biological systems 
Enzyme inhibition plays an important role in the regulation of biological systems 
(Oliver and Shenolikar, 1998) as well as in chemotherapy (Maggi et aI., 2000). Naturally, 
plants and animals have been reported to use poisons as a means of protecting themselves 
from predators. Many of these poisons function as enzyme inhibitors. In chemotherapy, 
most drugs function by inhibiting enzymes that are crucial in the pathways of both 
diseases (Cushman and Ondetti, 1995) and pathogenic organisms. Enzyme inhibitors also 
play an important role as insecticides, herbicides as well as disinfectants 
(Nomura et aI., 2005). 
1.8.1.1 Regulation of metabolic pathways 
Most cellular processes are mediated by enzymes. These processes are well regulated to 
ensure normal metabolism, and this is achieved by controlling enzyme activity 
(Garrett and Grisham, 2005). In vivo, enzyme activity can be regulated by the 
concentration of metabolites such as substrates and products. If regulation of enzyme 
activity occurs through the involvement of hormones or nervous stimulation, it is known 
as extrinsic control. If it proceeds without any external influence, it is termed intrinsic. 
Glycolysis is one example of a metabolic process that is regulated through enzyme 
inhibition. In one of the glycolytic pathway steps, D-fructose 6-phosphate is converted to 
D-fructose 1,6-bisphosphate by phosphofructokinase in the presence of A TP. High A TP 
concentrations have been reported to inhibit the activity of phosphofructokinase, thus 











Chapter I General Introduction 
1.8.1.2 Role in Chemotherapy 
Enzyme inhibitors have a long history of use as chemotherapeutic agents 
(Szedlacsek and Duggleby, 1995). Viagra, a drug that is used to remedy erectile 
dysfunction, functions by inhibiting cGMP specific phosphodiesterase type 5, an enzyme 
that degrades the signaling molecule cyclic guanosme monophosphate 
(Maggi et aI., 2000). Equally important is the role that enzyme inhibitors play in the 
treatment of HIV -AIDS. In the life cycle of HIV infection (Figure 8), there are a number 
of drug targets that can be used to reduce the infection such as prevention of the binding 
of HIV-l gp120 to CD4 receptors as well as enzyme mediated processes. To date, the 
approved treatment of HIV infection has been restricted to two of the three target 
enzymes, HIV-l reverse transcriptase (HIV-l RT) and HIV-l protease (HIV-l PR) 
(Notka et aI., 2004, Marchand et aI., 2006). The above illustrate the important role played 












Chapter I General Introduction 
1.9 HIV-l Reverse Transcriptase as a target for Anti-HIV drugs 
HIV -1 RT plays a crucial role in the replication cycle of HIV. In general, RTs are not 
required for normal metabolic processes in the host cell, and are thus important targets 
for antiviral therapy (Sarafianos et aI., 1996, Pelemans et aI., 2000). The current 
antiviral drugs are targeted at the R T polymerase and not the RNase activity 
(Huang et aI., 1998). Inhibitors of RT catalysed polymerization are divided into 
two groups: nucleoside RT inhibitors (NRTls) and non-nucleoside RT inhibitors 
(NNRTIs). NRTls are substrate analogues that act by chain termination 
(Ren et aI., 2001, Pata et aI., 2004). The first drug to be approved for HIV therapy was 
AZT, a nucleoside inhibitor. This drug was, however, reported toxic to the host and 
complete inhibition of HIV replication was not attained (Merluzzi et aI., 1990). NNRTIs 
constitute compounds with a wide range of chemical formulae and are generally very 
specific for HIV -1 R T (Smerdon et aI., 1994, Ren and Stammers, 2005). These 
compounds inhibit HIV -1 RT by binding at an allosteric site, resulting in conformational 
changes that displace catalytic aspartate residues In the active site 
(Ren et aI., 2001, Pata et aI., 2004). Nevirapine is an example of a first line non-
nucleoside inhibitor and, like most NNR TIs, suffers from a rapid selection of resistant 
HIV strains. This resistance has generally been associated with Tyr 181 and Tyr 188 
mutations within the NNRTIs binding pocket (Ren and Stammers, 2005). 
1.9.1 Crystal structure of HI V-I RT bound to a non-nucleoside inhibitor 
NNRTIs have been reported to bind to the same hydrophobic pocket which results from 
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Chapter 1 General Introduction 
1.10 Objectives 
1.10.1 Main objective 
The main objective of this project was to investigate the inhibition of M-MLV RT and 
HIV-l RT activity by polyphenols extracted from the resurrection plant 
Myrothamnus flab ell ifolia 





Extraction, purification and characterization of polyp he no Is from 
M flabellifolia 
Development of a reverse transcriptase activity assay based on 
ethidium bromide fluorescence 
Investigating the inhibition ofM-MLV RT activity by polyphenols 
from M flabellifolia 
Investigating the inhibition of HIV -1 RT activity by polyphenols 











Chapter 2 Polyphenol extraction and characterisation 
CHAPTER 2 
POL YPHENOL EXTRACTION AND PURIFICATION 
2.1 INTRODUCTION 
Polyphenols can be extracted from both dry and fresh plant material. The sample is 
initially homogenized by grinding. Liquid nitrogen is often used when working with 
fresh material so as to facilitate the homogenization process. The use of liquid nitrogen 
also ensures that temperatures are kept as low as possible during grinding since high 
temperatures lead to polyphenol degradation (Makkar, 2003). 
Extraction of polyphenols from plant materials is performed by several methods, namely 
solvent extraction, solid phase extraction or supercritical fluid extraction. Solvent 
extraction separates soluble polyphenols from the sample material and is usually 
accompanied by sonication or microwave heating to make cell walls more permeable to 
the extracting solvent. Solid phase extraction may utilize hydrophobic cartridges which 
are employed to remove polyphenols from the solvent. It is sometimes used in 
combination with solvent extraction. Supercritical fluid extraction operates on the same 
principles as solvent extraction. The difference is that supercritical fluid extraction takes 
into account the properties of both gases and liquids for extraction. 
Methanol is often used as a solvent for extracting polyphenols although other solvents 
such as acetone, ethyl acetate and ethanol have also been reported 











Chapter 2 Polyphenol extraction and characterisation 
Estimation of polyphenol concentrations in the extract is now generally performed using 
Folin-Ciocalteau reagent (Hagerman, 2002). It is based on the reduction of M03+ to M02+ 
ions in an alkaline environment resulting in a yellow to blue color change, which is 
quantitated spectrophotometrically (Mozetic et ai., 2006). The reducing capacity of a 
given polyphenol extract is compared to a given standard such as gallic acid 
(Hagerman, 2002) and polyphenol concentrations are then expressed as equivalents of the 
standard used. 
The purification of polyphenol extracts IS often performed usmg column 
chromatography. Sephadex LH -20 has been reported to be an ideal 
matrix for separating natural products such as plant phenolic compounds 
(Pharmacia Handbook, Amarowicz et ai., 2003). Separation of the phenolic compounds 
on Sephadex LH-20 is achieved through both adsorption and size exclusion 
chromatography (Amarowicz et ai., 2003, Seger et ai., 2006). Tannins dissolved in 
alcohol are reported to bind to Sephadex LH-20, whereas low molecular weight phenolics 
do not (Hagerman, 2002). Elution of bound phenolics from the column is achieved by 
using solvents such as methanol, acetone or ethanol, and quite often aqueous mixtures of 
these solvents (Kantz and Singleton, 1990, Amarowicz et ai., 2003, Seger et ai., 2006). 
The purity of polyphenol preparations can be assessed by analytical HPLC. Reverse 
phase HPLC for instance utilizes a hydrophobic Cs or CIS alkyl bonded stationary phase 
and mobile phases of varying polarity. Compounds are generally eluted in-order of 
decreasing polarity (Escribano-Bailon and Santos-Buelga, 2003). Additional 
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MALDI-TOF mass spectrometry. MALDI-TOF.MS works by ionizing and transferring 
the sample (embedded in a solid matrix) from a solid state into a gas state. The matrix 
aids the solid-gas phase transition and facilitates the ionization of the sample. A laser 
beam supplies energy for this transformation. The ions are separated based on their mass 
to charge ratio with lighter molecular ions moving faster and hence detected earlier than 
heavier ions. MALDI-TOF has several advantages, which include the production of 
mainly single charged molecular ion for each parent molecule and the high precision with 
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2.2 MATERIALS AND METHODS 
2.2.1 Plant material 
M flabellifolia plant material was collected in Namibia at the edge of the central 
highlands and the coastal Namib Desert plains (GPS coordinates: S 22°25.001' 
EOI5°51.156') in the dehydrated state in the dry winter season (June). The collected 
material was stored in the dry state at 20°C. Identification of the plant material was done 
by Jill Farrant (Moore et aI., 2005a). 
2.2.2 Polyphenol extraction from Myrothamnus flabellifolia 
Polyphenols were extracted following the method by Makkar et aI., 1993. Air dried 
leaves of M flabellifolia were manually ground using a pestle and mortar to a fine 
powder in the presence of liquid nitrogen. The ground sample was passed through a 0.5 
mm mesh sieve and weighed. Hexane (20 ml) was added to two centrifuge tubes each 
containing 1.5 g of the sieved sample material. The tubes were purged with nitrogen gas, 
covered and then sonicated for 30 minutes at room temperature. The sonicated mixture 
was centrifuged for 10 minutes at 10,000 x g. The pellet was re-extracted with hexane 
and then dried in vacuo. Aqueous acetone (70 % (v/v) acetone, 20 ml) was added to the 
pellet, which was purged with nitrogen and sonicated as before, and then centrifuged. 
Acetone extraction was performed twice and the resulting supernatant extracts from both 
tubes were pooled. Solvent extraction was performed three times by adding hexane to 
the acetone extract solution in a separating funnel. Polyphenols were collected from the 
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rotory evaporation under reduced pressure at 30°C for two hours. The polyphenol extract 
was lyophilized and then stored at -20°C. 
2.2.3 Folin-Ciocalteau analysis of phenolics in crude and pure polyphenol extracts 
Total phenolics in the extract were determined using the method of Makkar, 2003. 
Aliquots of gallic acid (0 to 5 J..lg/ml) were transferred to different test-tubes and the 
volume made up to 0.7 ml with distilled water. Folin-Ciocalteau reagent (1 M, 0.3 ml) 
was added followed by 1.0 ml sodium carbonate (20 % w/v), to give a final volume of2.0 
ml. The tubes were vortexed and incubated for 2 hours at 20°C before measuring 
absorbance at 765 nm (Mozetic et ai., 2006). 
2.2.4 Polyphenol purification by Sephadex LH-20 
The crude lyophilized polyphenol extract (62 mg) was dissolved In 
aqueous methanol (10 % , 4 ml) by sonication for 5 min, after which, the 
relatively small amounts of insoluble material was removed by centrifugation. 
The supernatant fraction was applied to a Sephadex LH-20 
(Amersham Pharmacia Biotech AB SE-751 Uppsala Sweden) column 
(packed volume of 11 ml) equilibrated in water. Fractions were eluted with increasing 
concentrations of methanol in water (between 0 and 100 %). The absorbance at 280 nm 
of the fractions was determined to calculate the relative contribution to the original 
extract before samples were concentrated at 30°C, under reduced pressure in a rotary 
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2.2.5 HPLC analysis of the crude and pure polyphenol extracts 
High performance liquid chromatography (HPLC) analysis of the crude and purified 
polyphenols was performed using a Shimadzu LC-IO system (Japan) equipped with a 
Shimadzu SPD-M6A Photodiode array UV/VIS detector. Compounds were separated on 
a 250 mm x 4.6 mm, 5 !im particle size, Jones C 18 column (USA) equilibrated using 
0.1 % (v/v) trifluoroacetic acid (TF A) in water followed by a 0 - 100 % acetonitrile 
gradient in 0.1 TF A. The flow rate was 700 !iI/min, at room temperature (22°C). 
Fractions eluted from Sephadex LH-20 column were analysed singly or in combination 
with other fractions. Fractions were compared to one another by co-injection 
(10 !il each) and the predominant peak was assumed to be 3,4,5 tri-o-galloylquinic acid 
(Moore et aI., 2005b) 
2.2.6 MALDI-TOF.MS analysis of the crude and pure polyphenol extracts 
MALDI-TOF.MS analysis was performed according to the method of Moore et aI., 2005. 
The sample was dissolved in 50 % acetonitrile and analysed using 10 mg dihydrobenzoic 
acid (DHB) matrix dissolved in 1 ml of 60 % acetonitrile and 0.1 % TF A. The MALDI 
mass spectrometer (Perseptive Biosystems DE - Pro) was used in the delayed extraction 
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2.3 RESUL TS AND DISCUSSION 
2.3.1 Folin-Ciocalteau analysis of phenolics in crude and pure polyphenol extracts 
Gallic acid solution was mixed with the Folin-Ciocalteau reagent, followed by sodium 
carbonate. After incubation for two hours at room temperature, the absorbance was 
measured at 765 nm. The results showed a direct relationship between the reduction of 
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Figure 2.1: Standard curve for the Folin-Ciocalteau assay using gallic acid as a standard. 











Chapter 2 Polyphenol extraction and characterisation 
2.3.2 Polyphenol purification by Sephadex LH-20 
The polyphenol extract from M flabellifolia leaves was dissolved in aqueous methanol 
and fractionated using a Sephadex LH-20 column with increasing concentration of 
aqueous methanol. The elution was monitored by measuring the absorbance at 
280 nm. The aim of this analysis was to isolate 3,4,5 tri-O-galloylquinic acid (TGQ), 
the major polyphenol from Namibian M flabellifolia leaves (Moore et al. 2005). 
The chromatographic profile with five peaks (F], F 3-F 6) of 280 nm absorbing 
material is shown in Figure 2.2. No components were eluted using 10 % methanol 
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Figure 2.2: The elution profile of polyphenols eluted from a Sephadex LH-20 column using water 
The absorbance was measured at 280 nm 
Two independent experiments were performed and similar elution profiles were obtained 
in both cases. The amount of polyphenols in each fraction was estimated by measuring 
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as a percentage of the total absorbance of the original polyphenol sample. The largest 
amount of polyp he no Is was present in F6 followed by F5 and F4 . FJ and F3 registered the 
lowest amounts. 
Table 2.1: An estimation of the percentage of polyp he no Is in each fraction eluted from Sephadex LH-20 
Fraction Amount of polyphenol (%) 
11 ± 1.0 
12 ± 0.5 
18 ± 0.2 
24 ± 6.0 
38 ± 6.0 
The water solubility of the lyophilized polyphenols from each fraction was tested. It was 
observed that F J, F 3 and F 4 readily dissolved in water, whereas F 5 and F 6 were not readily 
soluble. It has been reported (Kantz and Singleton, 1990) that non-polymeric polyphenols 
are eluted from the Sephadex column matrix by 60 % methanol whereas polymeric 
polyphenols require more hydrophobic solvents. Fractions F 5 and F 6 probably contained 
several larger galloylquinic acid polymers (Moore et aI., 2005), and may account for their 
insolubility and tighter binding to the column. This observation was supported by the 
fact all the fractions had ultraviolet absorption maxima near 280 nm which is 












Chapter 2 Polyphenol extraction and characterisation 
2.3.3 HPLC analysis of the crude and pure polyphenol extracts 
Polyphenol fractions purified USIng Sephadex LH-20 chromatography were 
analysed using C 18 reverse phase HPLC. Each fraction was screened for the 
presence of 3,4,5 tri-O-galloylquinic acid. The HPLC profiles for the crude and 
pure polyphenol fractions are shown in Figure 2.3. The HPLC profile for the crude 
extract showed 6 peaks, with one characteristic major peak. The first fraction (F 1) eluted 
from the Sephadex LH-20 contained at least 4 peaks with very small amount of 
3,4,5 tri-O-galloylquinic acid. 
The HPLC profile for fraction F 3 showed one large peak. It was observed that the 
retention time for the single peak in F3 was similar to the retention time for the major 
peak of the crude extract profile. This was confirmed by co-injecting the two fractions 
onto the HPLC column. The profile showed an enhanced peak at the same retention 
time, suggesting that 3,4,5 tri-O-galloylquinic acid was eluted with 30 % methanol. The 
profile for polyphenols eluted with 50 % methanol (F 4) also showed a single major peak. 
This peak was confirmed by co-injection with F3 to be 3,4,5 tri-O-galloylquinic acid, 
suggesting that 3,4,5 tri-O-galloylquinic acid was still bound to the column. The profile 
for 70 % methanol (F 5) showed four elution peaks. Co-injecting it with F 3, it became 
evident that 3,4,5 tri-O-galloylquinic acid was not present. As expected, 
3,4,5 tri-O-galloylquinic acid was also not detected in the 100 % methanol eluted fraction 
(F6). Based on these results, it would appear that 3,4,5 tri-O-galloylquinic acid was 
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Figure 2.3: HPLC profile for crude and purified polyphenol fractions 
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2.3.4 MALDI-TOF.MS analysis of the crude and pure polyphenol extracts 
The MALDI-TOF mass spectra for the crude and pure polyphenol extracts are shown in 
Figure 2.4. The peaks observed at m/z ratio below 600 were due to the dihydrobenzoic 
acid matrix. The spectrum of the crude extract showed several peaks with m/z ratios 
ranging from 600-1800. This range included two peaks "a" and "b" at m/z ratios of 
671.34 and 687.34 respectively. The spectra for fractions purified by 30 % (F3) and 50 % 
(F 4) methanol showed two major peaks "a" and 'ob" with mlz ratios similar to the two 
peaks 'Oa" and "b" in the spectrum of the crude polyphenol extract. The molecular weight 
of a polyphenol fraction from M flabellifolia leaves eluted with 30 or 50 % methanol 
from sephadex LH-20 has been reported to be 648 Da (Moore et aI., 2005). No peak was, 
however, observed at mlz ratio of 648, characteristic of 3,4,5 tri-O-galloyquinic acid. 
It has been reported that the presence ofNa+ and K+ ions during desorption and ionization 
results in the formation of [M+Nat and [M+Kt, where M represents the molecular 
weight of the parent molecule (Reed et ai, 2005). The calculated m/z ratio of 
3,4,5 tri-O-galloyquinic acid together with a sodium ion was 670.99 and the observed 
average ratio was 671.41. The calculated mlz ratio of 3,4,5 tri-O-galloyquinic acid 
together with a potassium ion was 687.10 whereas the observed average ratio was 687.39. 
It can therefore be concluded that the peaks observed at 671.41 and 687.39 were the Na + 
and K+ adduct ions of 3,4,5 tri-O-galloyquinic acid molecule respectively. The spectra of 
the fractions eluted with 70 % (F 5) and 100% (F 6) methanol did not show any evidence 
for the presence of 3,4,5 tri-O-galloyquinic acid. The latter spectrum contained higher 
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or oxidative addition of gallic acid moieties to 3,4,5 tri-O-galloylquinic acid 
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Figure 2.4: MALDI-TOF spectra of the crude polyphenol extract (crude) and fractions purified by 
Sephadex LH-20 column chromatography: F3-F6. 











Chapter 3 Enzymology of Reverse Transcriptase 
CHAPTER 3 
ENZYMOLOGY OF REVERSE TRANSCRIPTASE 
3.1 Introduction 
DNA polymerases are divided into seven classes including reverse transcriptases (RTs) 
based on sequence homologies and crystal structures (Yang et ai., 2004). RTs are known 
to have RNA/DNA-dependent polymerase and ribonuclease (RNase) H activities 
(Fisher et ai., 2005). HIV -1 RT is one important example of a RT as it plays a crucial 
role in the life cycle of human immunodeficiency virus type (HIV-l) 
(Goldschmidt et ai., 2006). As such, it has been a major target of many antiviral drug 
therapies such as Nevirapine. As a non-nucleoside inhibitor, Nevirapine suffers from a 
rapid selection of resistant HIV strains. This resistance has generally been associated with 
Tyr 181 and Tyr 188 mutations within the NNR TIs binding pocket (Ren and Stammers, 
2005). Thus the need for new inhibitors for HIV -1 R T can not be over-emphasized. 
Moloney murine leukemia virus reverse transcriptase (M-MLV RT) is another RT, which 
is extensively used in molecular biology applications such as cDNA synthesis on account 
of its relatively low cost. 
Assays for RT activities are widely based on the incorporation of radio-labeled 
deoxynucleotides into the primer template complex (Nishizawa et ai., 1989). In this 
study, a non radioactive assay for RT activity was developed. The assay was based on 
ethidium bromide fluorescence and it was successfully optimized using M-MLV RT. 
Finally, the inhibition of HI V-I and M-MLV RTs by crude and pure polyphenol extracts 
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3.2 Materials and Methods 
3.2.1 Chemicals and Reagents 
Calf thymus DNA was purchased from Sigma. Poly( rA ) template (approximately 1000 
bases) was a donation from Ribotech. An oligo(dThs primer was purchased from UCT 
MCB DNA Services. The reverse transcriptase enzymes M-MLV-RT and HIV RT were 
purchased from Promega and Ambion respectively. The ultra-pure lithium salts of dTTP, 
dATP, dCTP, and dGTP were products of Bioline. dAMP, ATP, and thymidine were 
purchased from Sigma. Thymine was purchased from Merck. Tris-HCl and ethidium 
bromide were from Research Organics and Merck respectively. Sodium pyrophosphate 
was purchased from Riedel-De Hahn. 
3.2.2 DNA Quantification by Fluorometry 
Calf thymus DNA (ctDNA) was chosen as a standard for DNA quantification. ctDNA 
was dissolved in double distilled water and its final concentration was determined by 
spectrophotometry (NanoDrop ND-IOOO Spectrophotometer). ctDNA was diluted in 
Tris-HCl buffer (40 mM Tris, 100 mM NaCl, pH 7.2) to give a concentration range of 
a to 8 flg/m!. Ethidium bromide was added to a final concentration of 2.5 flg/m!. 
Tris-HCl buffer was added to bring the final volume to 1.0 m!. Tris-HCl buffer and 
ethidium bromide were prepared using double distilled and sterilized water. Fluorescence 
was measured using an Aminco SPF 500 fluorometer. The excitation wavelength 
was 545 nm with a 5 nm bandpass, and the emission wavelength was 605 nm 
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ctDNA-ethidium bromide complex was performed in the presence of 34 ~M final 
polyphenol (3,4,5 tri-O-galloylquinic acid) concentration. 
3.2.3 Poly (rA) and oligo (dThs titration 
Poly (rA) template solution was prepared by dissolving the polymer in RNase free water 
and the concentration was determined spectrophotometricaly. The poly (rA) solution was 
diluted to a working concentration of 1.00 ~g/~1. Poly (rA) (2.5 ~g) was mixed with 
various amounts of oligo(dTb primer up to 5 ~g. The final volume of the solution of 
poly (rA) and oligo (dTh5 mixture was made to 50 ~l with RNase free water. Poly(rA) 
was omitted from the control reaction. The mixture was incubated at 65 DC for 5 minutes, 
chilled on ice for at least 1 minute and then incubated at room temperature for 15 
minutes. Tris-HCl buffer (945.0 ~l, pH 7.2) and ethidium bromide (5 ~l, 0.5 mg/ml) was 
added to the mixture to bring the final volume to 1.0 ml. Ethidium bromide fluorescence 
was measured as before. 
3.2.4 Assay for M-MLV and HIV-l RT activity 
First strand cDNA synthesis using M-MLV and HIV-l RT was performed according to 
their respective manufacturer's protocol with some changes. Poly (rA) template 
(12.5 Ilg) and oligo (dT) 25 primer (0.25 Ilg) were mixed to give a total volume of25 Ill. 
The mixture was centrifuged briefly and then incubated at 65 DC for 5 minutes. The 
mixture was then chilled on ice for at least 1 minute and allowed to stand at room 
temperature for 15 minutes. Reagents for M-ML V RT assay were added to the 
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dTTP (up to 4 mM final concentration), and RNase free water. The mixture was 
centrifuged briefly to bring the contents to the bottom of the tube. M-ML V RT enzyme 
(l70 Units, 0.071 !lM) was added to the mixture to give 100.0 J.lI final assay volume, 
mixed by gently tapping the bottom of the tube, briefly centrifuged as before and 
then immediately incubated at 37 Dc. Reagents for HIV -I RT assay were added to the 
poly (rA).oligo (dTb mixture as follows: HIV-l RT buffer (lOX, 16.7 J.lI), dTTP 
(0 to 2 mM) and RNAse free water to make the final volume to 25 !ll. The mixture was 
treated as per the M-MLV RT assay before addition of HIV-l RT enzyme 
(20 U, 0.17 !lM). The mixture was incubated at 42 Dc. Aliquots (20 J.lI) were taken at 
every 5 minute time interval and immediately added to Tris-HCI buffer (975 J.lI pH 7.2,) 
containing ethidium bromide (2.5 !lg/ml) to a final volume of 1.0 ml. Ethidium bromide 
fluorescence was measured as before. 
3.2.5 Effect of potential inhibitors on M-ML V RT activity 
The assay for M-MLV RT activity was performed in the presence of 1.0 mM dTTP and 
either dA TP, dCTP, dGTP, dAMP, ATP, thymidine, thymine, pyrophosphate or 
phosphate. All additional compounds were added to a final concentration of 1.0 mM. 
3.2.6 Effect of polyphenols on M-MLV and HIV-l RT activity 
The effect of crude and purified polyphenols (F I , F2 -F6) on enzyme activity was initially 
performed using M-ML V RT in the presence of 1.2 J.lg/ml final polyphenol 
concentration. The dTTP and Mg2+ concentrations were fixed at 1.0 and 3.75 mM 
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diluted and re-assayed. The most effective polyphenol fraction was further analysed to 
establish the 50 % inhibitory concentration (lC50) values for both M-MLV and HIV-l 
R Ts. Polyphenols were omitted from control reactions. The effect of Nevirapine on 
M-MLV and HIV-l RT was performed using Nevirapine concentrations of up to 1.0 mM 
and 1.0 11M for M-MLV and HIV-l RT respectively. 
3.2.7 Mode of 3,4,5 tri-O-galloylquinic acid inhibition of M-MLV and HIV-l RT 
activity 
An enzyme activity assay to determine the nature of the polyphenol inhibition of M-ML V 
and HIV -1 RT was carried out in the presence of 0.5 11M and 34 11M 
3,4,5 tri-O-galloylquinic acid respectively. The concentration of Mg2+ ions was held 
constant at 3.75 mM and dTTP concentrations up to 1.0 mM were used for M-MLV RT, 
whereas 5.0 mM Mg2+ and dTTP concentrations up to 0.25 mM were used for HIV -1 RT. 
3.2.8 Reversibility of 3,4,5 tri-O-galloylquinic acid binding to M-MLV and 
HIV-l RT 
To determine how tightly polyphenols were bound to the M-ML V RT enzyme, soluble 
PVP and BSA were added to the cDNA synthesis assay, either alone or in combination 
with 3,4,5 tri-O-galloylquinic acid. The final concentration of PVP and BSA in the assay 
mixture was 0.03 mg/ml, resulting in the molar ratio of PVP to M-MLV RT and BSA to 
M-ML V RT of 11: 1 and 63: I respectively. The final 3,4,5 tri-O-galloylquinic acid 
concentration used was 2.4 11M. The assay was performed as follows: (i) PVP or BSA 











Chapter 3 Enzymology of Reverse Transcriptase 
then immediately incubated at 37 DC. (ii) The enzyme was initially mixed with 
3,4,5 tri-O-galloylquinic acid, briefly mixed by tapping the tube at the bottom and 
centrifuged to mix the contents and then allowed to stand in ice for 5 minutes. 
PVP or BSA was then added and the mixture allowed to stand on ice for another 5 
minutes before performing the enzyme assay. (iii) PVP or BSA was initially added to the 
assay mixture containing 3,4,5 tri-O-galloylquinic acid, mixed thoroughly and allowed to 
stand on ice for 5 minutes before adding M-ML V RT. 
The mode of 3,4,5 tri-O-galloylquinic acid inhibition of HIV-I RT was performed in the 
presence of 100 f..lM 3,4,5 tri-O-galloylquinic acid and 11.0 f..lM BSA. The molar ratio of 
BSA to HIV-I RT was 63:1. The enzyme activity assay was initially performed in the 
presence of 3,4,5 tri-O-galloylquinic acid and BSA alone. Secondly, The HIV-I RT 
enzyme was mixed with 3,4,5 tri-O-galloylquinic acid and allowed to stand for 5 minutes 
on ice before BSA addition. Finally, BSA was mixed with 3,4,5 tri-O-galloylquinic acid, 
allowed to stand for 5 minutes on ice before HIV -I RT enzyme addition. cDNA synthesis 
by HIV-I RT was performed at 42DC. Ethidium bromide fluorescence was measured to 
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3.3 RESUL TS AND DISCUSSION 
3.3.1 DNA Quantification 
The RT assay was designed to synthesise cDNA from a poly (rA) template using an 
0Iigo(dT)25 primer together with dTTP. The initial objective was to set up a method to 
determine low concentrations of dsDNA in solution. The method used was based on 
ethidium bromide fluorescence and assumes that the binding of ethidium bromide to 
dsDNA and its subsequent fluorescence is equivalent to binding to cDNA. Although the 
fluorescence of free ethidium bromide in solution is very low, the fluorescence is 
greatly enhanced when it intercalates into the DNA double helix. This enhanced 
fluorescence is thought to arise from shielding of the ethidium bromide from 
the quenching effect of the surrounding water molecules (Garbett et aI., 2004). 
Calf thymus DNA was chosen as the standard to determine the DNA concentration in 
solution. The results showed that the ethidium bromide fluorescence was directly 
proportional to the DNA concentration in the range of 0 - 8 Ilg/ml. (Figure 3.1). 
The R2 value of 0.997 demonstrated a linear response for ethidium bromide fluorescence 
over this concentration range. The limit of sensitivity using this method was 
approximately 0.1 Ilg/ml. In comparison, the limit of detection using a UV 
spectrophotometer is approximately 5 Ilg/ml assuming that a 1 mg/ml of DNA solution 
has an A260 nm = 20. Polyphenols through their planar aromatic groups have the 
potential to either enhance or quench the fluorescence of the ethidium bromide-DNA 
complex in solution. The effect of these polyphenols on the fluorescence of ctDNA-
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3,4,5 tri-O-galloylquinic acid concentration. The results showed no significant change in 
the fluorescence of the ctDNA-ethidium bromide complex in the presence or 
absence of polyphenols. Furthermore fluorescence measurements for enzyme assays 
(section 3.2.4 - 3.2.6) were performed after a 50 fold dilution of the assay mixture 
(including the polyphenol concentration) while ethidium bromide concentration remained 
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Figure 3.1: Calibration curve for the determination of DNA in solution. 
Ethidium bromide in water was added to a final concentration of 0.025mg/ml to various concentrations of 
calf thymus DNA in Tris-HCI pH 7.2. The fluorescence was determined at 605 nm (excitation 545nm). The 
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3.3.2 Poly (rA) and oligo(dThs titration 
The RT assay was based on the elongation of an oligo.dT primer of length 25 nucleotides 
(oligo (dT) 25) bound to a poly (rA) template oflength approximately 1000 nucleotides. In 
order to determine whether binding of the primer to the template occurred and whether 
this was saturable at the theoretical maximum, increasing amounts of primer were added 
to a fixed amount of template. The amount of double-stranded nucleic acid formed would 
be determined from the ethidium bromide fluorescence. After heating at 65°C for 5 mins 
to achieve complete denaturation, the samples were rapidly cooled on ice for 5 minutes. 
Ethidium bromide was then added to a final concentration of 25 llg/ml and the 
fluorescence determined as described. The results showed that ethidium bromide 
fluorescence increased linearly up to when 2.5 llg oligo (dTh5 was added 
per 2.5 llg poly (rA), after which it remained constant. Thus an equivalent amount of 
oligo (dT) 25 was required to form the maximum amount of double stranded nucleic acid, 
showing that the entire length of the poly (rA) template interacted with the primer when 
sufficient primer was present. No change in the ethidium bromide fluorescence was 
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Figure 3.2: Ethidium bromide fluorescence as a function of the concentration of oligo (dT) 25' 
Oligo (dTb was added to 2.5/lg/ml poly (rA) (_) to a final concentration up to 5/lg/ml. Ethidium bromide 
was then added to 25 /lg/ml and the fluorescence was detennined as before. Poly (rA) was omitted from the 
control titration. (0). 2.5 /lg of oligo (dTb added corresponded to a theoretical 5.0 /lg cDNA formed. The 
data represent the mean (± SO) of three replicate samples. 
The response of ethidium bromide binding to DNA (Figure 3.1) was compared with its 
binding in the linear region to the oligo (dT) 25.poly (rA) duplex (Figure 3.2). These 
responses were found to be 2012 ± 7 and 2222 ± 54 U/llg/ml respectively suggesting that 
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3.4 Enzymology of M-MLV Reverse Transcriptase 
The RT assay was designed to extend the oligo (dTb primer bound to the poly (rA) 
template using dTTP in the presence of3.75 mM Mg2+. A ratio of I: 50 oligo (dTbpoly 
(rA) (gig) was used together with dTTP in the concentration range 0.0 to 4.0 mM. If the 
reaction were allowed to go to completion, 25.0 Ilg of double stranded cDNA would be 
formed. Samples were removed from the assay mixture at selected time points, ethidium 
bromide was added to 25 Ilglml final concentration and the fluorescence determined. The 
linear portion of the reaction profile yielded Vo, the initial velocity of the reaction. 
Typical reaction profiles are shown in Figure 3.3. The concentration of cDNA 
synthesized was calculated from the ethidium bromide fluorescence. 
5 
4 
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Figure 3.3: cDNA synthesis using selected dTTP concentrations as a function of time. 
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A plot of the initial velocity (Vo) against the substrate concentration showed that an 
increased reaction rate occurred as a function of the dTTP concentration. This rate 
reached a maximum at 1.0 mM dTTP (Figure 3.4). Further addition of dTTP resulted in a 
marked decrease in the rate of cDNA synthesis, which was virtually zero in the presence 
of 4.0 mM dTTP. This behaviour, referred to as substrate inhibition, where the rate of 
catalysis increases with an increased substrate concentration to a maximum velocity after 
which the rate decreases, has been reported as a common deviation from normal 
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Figure 3.4: Initial rate (Vo) for the formation of cDNA as a function of the dTTP concentration. 
The assay was carried out in the presence of3.75mM MgCI2 . 
Kinetic data implicating substrate inhibition needs to be interpreted with care. 
Competitive substrate inhibition has been implicated in causing substrate inhibition, but 
its effect becomes negligible when initial rates are used (Verhamme et aI., 1988). The 
presence of contaminating noncompetitive inhibitors in the substrate has also been 
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this was unlikely as the dTTP was at least 99 % pure. Another factor that can cause 
substrate inhibition is a substrate co-factor (Dixon & Webb, 1979). M-MLV reverse 
transcriptase requires Mg2+ for its catalytic activity and this would be considered to be a 
co-factor. Since high dTTP concentrations would bind to the Mg2+ present in the assay 
mixture (Oelschlaeger et aI., 2007), it is possible that the substrate inhibition observed at 
high substrate concentration was caused by insufficient free Mg2+ in the assay mixture. 
To investigate if this was indeed the case, the assay was repeated in the presence of 
7.5 mM Mg2+. The results showed that there was no difference in the reaction rate up to 
1 mM dTTP when compared with the reaction in the presence of 3.75 mM Mg2+ 
(Figure 3.5). However, the maximum rate observed now occurred at 2 mM dTTP, after 
which the rate was found to decrease. This decrease was markedly less than that observed 
in the presence of 3.75 mM Mg2+. When the molar ratio Mg2+: dTTP was 1:1, the 
M-ML V RT activities observed were equivalent, strongly suggesting that inhibition of 
enzyme activity at high substrate concentration was probably due to interaction between 















::::I. 0.4 ..... 
I!! 
'n; 





0 1 2 3 4 5 6 7 8 9 
IdTTP] mM 
Figure 3.5: Initial rate (Vo) for the formation of cDNA as a function of the dTTP concentration. 
The assay was carried out in the presence of either 3.75 mM MgClc (_) or 7.5 mM MgClc (D). The data 
represent the mean (± SO) of two replicate samples. 
3.4.1 Kinetic parameters for M-MLV RT activity 
Kinetic parameters for an enzyme that exhibits inhibition at high substrate concentrations 
can be estimated by ignoring the contribution of higher substrate concentrations. The 
V max and Km are then estimated from the normal Michaelis-Menten kinetics using a 
double-reciprocal plot (Figure 3.6). V max was found to be 0.8 ± 0.2 flM (bp)/min and Km 
was found to be 1.06 ± 0.22 mM irrespective of whether the Mg2+ concentration was 3.75 
or 7.5 mM. Addition of the kinetic data observed at high substrate concentrations in the 












Chapter 3 Enzymology of Reverse Transcriptase 
35 
'c' 25 





-5 -5 20 
1/ldITPl mM 
Figure 3.6: Double-reciprocal plot of the initial velocity of dTTP incorporation into poly (rA) : oligo 
(dT2S) by M-MLV RT as a function of the dTTP concentration. 
3.4.2 Effect of potential competitive inhibitors on M-ML V RT activity 
A number of nucleotide triphosphates and similar molecules were investigated as to 
whether these inhibited the M-MLV RT reaction. The compounds tested were dGTP, 
dCTP, dATP, ATP, dAMP, ADP, thymidine, thymine, pyrophosphate and phosphate. 
The Mg2+ and dTTP concentrations were fixed at 3.75 and 1.0 mM respectively and the 
compounds tested were present at a final concentration of 1.0 mM. The inhibition of 
M-MLV RT activity of these compounds was compared to the inhibition observed with 
2 mM dTTP. 
The results showed that all nucleotide triphosphates (dGTP, dCTP, dA TP and A TP) 
inhibited M-MLV RT activity significantly, and were comparable to the inhibition 
observed in the presence of 2.0 mM dTTP (Table 3.1). Pyrophosphate also showed a 
significant but lesser inhibition by comparison with the nucleotide triphosphates. 
The other compounds tested did not show any significant inhibition. No difference was 
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showed that the presence of a triphosphate on the nucleotide is crucial. Whereas the 
triphosphate inhibition observed could be due to the binding of Mg2+ ions, the 
pyrophosphate inhibition observed might result from two distinct causes. Firstly, 
pyrophosphate might bind to the positions where the ~ and y phosphates bind thereby 
competing with nucleotide triphosphate binding, and secondly pyrophosphate is a product 
of the R T reaction. Thus increased pyrophosphate concentrations would favour the 
reverse reaction and reduce the forward enzyme activity. It was considered that the 
observed inhibition was not due to Mg2+ binding, since nucleotide diphosphates would 
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Table 3.1: M-MLV RT activity inhibition by potential competitive inhibitors. 
I mM of each test compound was mixed with ImM dTTP and then assayed for enzyme activity. The data 
were compared with the activity observed in the presence of 2.0 mM dTTP which resulted in 35 ± 3 % 


















Inh ibition (%) 
35 ± 3 
39 ± 3 
41 ± 6. 
43 ± 4 
7 ± 5 
38 ± 0.3 
7 ± 8 
9 ±7 
1O± 4 












Chapter 3 Enzymology of Reverse Transcriptase 
3.4.3 Effect of polypheools 00 M-MLV RT activity 
Preliminary data showed that crude polyphenol extracts of M flabellifolia leaves 
inhibited M-ML V RT activity in vitro. The crude extract was separated into various 
fractions using Sephadex LH-20 chromatography which were analysed by HPLC and 
MALDI-TOF mass spectrometry. Only the main constituent in fractions F3 and F4 was 
identified and this was found to be 3,4,5 tri-O-galloylquinic acid. The assay for 
M-MLV RT activity was, however, performed on all HPLC fractions although the main 
constituents were unknown. The final concentration of each polyphenol fraction used to 
test for the inhibitory activity of M-ML V RT was 1.2 Ilg/ml. At this concentration, the 
crude extract and fractions FI, F5 and F6 inhibited M-MLV RT by up to 84 % 
(Table 3.2). In contrast, complete inhibition was found for fractions F 3 and F 4. These 
fractions were diluted 4-fold and re-assayed. At a concentration of 0.3 Ilg/ml, these 
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Table 3.2: Effect of crude and pure polyphenol fractions on M-MLV RT activity. 
The data represent the mean (± SD) of three replicate samples. Fractions F3 and F4 were diluted and then 
re-assayed at a final concentration of 0.3 Ilg/ml. 
Inhibition (%) 
Polyphenol fraction 1.2 ~g/ml 0.3 ~g/ml 
Crude extract 54 ± 10 
F, 34± 8 
F3 98 ± 0.2 31 ± 5 
F4 98 ± 0.3 41 ± 8 
Fs 33 ± 2 
F6 84± 2 
All further work on polyphenol-mediated RT inhibition was performed using fraction F3, 
pure 3,4,5 tri-O-galloylquinic acid. The concentration of 3,4,5 tri-O-galloylquinic acid 
required for 50 % inhibition of M-MLV RT (ICso) was determined by adding various 
concentrations up to 0.9 !lM of 3,4,5 tri-O-galloylquinic acid to the enzyme assay. The 
results showed an exponential response of M-ML V RT inhibition in this concentration 
range (Figure 3.7) and the ICso was estimated to be 0.5 ± 0.004 !lM. 
Since polyphenols are known to chelate divalent metal ions, it is possible that the 
observed inhibition could be due to the polyphenol binding of Mg2+. This however was 
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Figure 3.7: Inhibition of M-MLV RT activity as a function of the log (3,4,5 tri-O-galloylquinic acid) 
concentration. 
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3.4.4 Mode of M-MLV RT inhibition by 3,4,5 tri-O-galloylquinic acid 
Having established that 3,4,5 tri-O-galloylquinic acid inhibited M-MLV RT 
activity, the mode of this inhibition was investigated. The concentrations 
of 3,4,5 tri-O-galloylquinic acid and Mg2+ were fixed at 0.5 J..lM and 
3.75 mM respectively. A Lineweaver-Burke plot of the data showed non-competitive 
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Figure 3.8: A Lineweaver-Burk plot of dTTP incorporation into poly (rA).oligo(dT2s) by 
M-MLV RT as a function of dTTP concentration in the presence (_) and absence (0) of 
3,4,5 tri-O-galloylquinic acid. 
The data represent the mean (±SO) of three replicate samples 
The apparent change in maxImum velocity (V max app) In the presence of 
3,4,5 tri-O-galloylquinic acid IS represented by the following equation 
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This equation is useful for estimating the inhibition constant (K j) since V max and Vi max can 
be deduced directly from the Lineweaver-Burke plot. The kinetic parameters are 
summarized in Table 3.3. The inhibition constant Kj represents the ICso for a given 
compound. The value was very similar to the previous estimate of the ICso 
(Figure 3.7). The Km and V max values of the uninhibited enzyme were very similar to 
those obtained previously (Figure 6), even though different batches of the enzyme were 
used 
Table 3.3: Kinetic parameters for dTTP incorporation into poly (rA):oligo(dTb complex using 
M-MLV RT, in the presence and absence of 3,4,5 tri-O-gaUoylquinic acid 
Reaction velocity units represent the concentration of base pairs incorporated per minute 
Parameter No TGQ added TGQ added 
V max (~M/min) 0.95 ± 0.03 
I 
V max (~M/min) 0.36 ± 0.03 
Km (mM) 0.90 ± 0.15 
Kim (mM) 0.90 ± 0.15 
K j (~M) 0.31 ± 0.05 
Non-competitive inhibition is exhibited by compounds with structures different from the 
substrates, in this case the nucleotide triphosphates (NTP's). The structure of 
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structure of the NTP's. Non-competitive inhibitors bind to the enzyme at a site distinct 








E(TGQ) + S 
m .. E(TGQ)S E + TGQ + P 
The scheme shows that the 3,4,5 tri-O-galloylquinic acid binds to both the free enzyme 
(E) and the enzyme substrate complex (ES). In non-competitive inhibition, the affinity of 
the enzyme for the substrate is unaffected by the presence of the inhibitor and vice versa, 
such that K j = K/j (Whiteley, 2000). 
3.4.5 Reversibility of 3,4,5 tri-O-galloyJquinic acid binding to M-MLV RT 
The binding of inhibitors to enzymes can either be reversible or irreversible. Reversible 
binding involves dissociation (at different rates) of the enzyme-inhibitor complex 
whereas no dissociation takes place during irreversible inhibition. To determine the 
reversibility of 3,4,5 tri-O-galloylquinic acid binding to M-MLV RT, an enzyme activity 
assay was performed in the presence of 3,4,5 tri-O-galloylquinic acid together with either 
PVP or BSA, which were used as a polyphenol binding agent and a competing protein 
respectively. The Mg2+ concentration was fixed at 3.75 mM. The results showed that the 
M-MLV RT activity in the presence of PVP and BSA alone was similar to 
that in their absence (Figure 3.9), showing that PVP and BSA did not inhibit 
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3,4,5 tri-O-galloylquinic acid was approximately 7 %. PVP or BSA addition subsequent 
to 3,4,5 tri-O-galloylquinic acid addition did not restore the activity of the enzyme, and in 
each case the activity was similar to that in the presence of 3,4,5 tri-O-galloylquinic acid 
alone. Since PVP was added at a molar ratio of PVP : M-ML V RT of 106: 1 and BSA at a 
molar ratio of BSA:M-MLV RT of 63:1, it was apparent that 3,4,5 tri-O-galloylquinic 
acid was tightly or irreversibly bound to the enzyme. Addition of the M-MLV RT 
to 3,4,5 tri-O-galloylquinic acid in the presence of either PVP or BSA increased 
the enzyme activity to 22 and 37 % respectively. The molar ratio of BSA 
and PVP to 3,4,5 tri-O-galloylquinic acid was 5: 1 and 8: 1 respectively,. 
The binding of 3,4,5 tri-O-galloylquinic acid to RT was therefore abnormally strong in 
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Figure 3.9: Effect of PVP and BSA on M-MLV RT activity in the absence and presence of 0.9 JIM 
3,4,5 tri-O-galloylquinic acid. 
The enzyme activity assay was performed as follows: (A) no addition,; (8) PVP; (C) BSA; (0) 0.9 JIM 
3,4,5 tri-O-galloylquinic acid; (E) Enzyme + 3,4,5 tri-O-galloylquinic acid, then PVP; (F) Enzyme + 3,4,5 
tri-O-galloylquinic acid, then BSA; (G) PVP + 3,4,5 tri-O-galloylquinic acid, then Enzyme; (H) BSA + 
3,4,5 tri-O-galloylquinic acid, then Enzyme. The data represent the mean (± SO) of three replicate 
samples. 
It has been reported that the type and strength of the interaction between polyphenols and 
proteins is influenced by their functional groups (Hagerman, 2002). The hydroxyl groups 
on the galloyl moiety are thought to play a crucial role in the interaction of galloyl-
containing polyphenols with proteins (Kawamoto et aI., 1995). Phenylalanine and 
proline residues have been considered to be the polyphenol binding sites on the protein 
(Charlton et aI., 2002) and it has been reported that the polyphenol affinity for protein 
was dependent on the proline content (Hagerman and Butler, 1981). Although the total 
phenylalanine and proline contents of the BSA and M-ML V RT are similar at 10.2 and 
10.6 mol % respectively, BSA has significantly higher phenylalanine content whereas 
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hydrophobic amino acid with a hydropathy index of 2.8, proline is a hydrophilic amino 
acid with a hydropathy index of -1.6 (Kyte and Doolittle, 1982). Thus phenylalanine 
residues would tend to be buried in most proteins (Charlton et aI., 2002), 
leaving proline as the only effective polyphenol binding site. This is a possible reason 
why 3,4,5 tri-O-galloylquinic acid binding to M-ML V RT was significantly stronger 
than to BSA. 












Nevirapine, a derivative of dipyridodiazepinone, is a non-nucleoside reverse transcriptase 
inhibitor widely used in the prevention of mother to child HIV transmission. It has been 
shown to bind to HIV-l RT non-competitively, resulting in disruption of the enzyme 
catalytic site (Riska et aI., 1999). Nevirapine was dissolved in 40 % DMSO and its effect 
on M-ML V RT activity was investigated using different concentrations up to 1.0 mM. No 
effect was observed either for Nevirapine or for DMSO alone used as a control. 
Nevirapine has been reported to be a highly specific HIV-l RT inhibitor but ineffective 
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(Smerdon et aI., 1994; Merluzzi et aI., 1990). This specificity could account for its 
inactivity against M-MLV RT even at concentrations ten times higher than the ICso for 
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3.5 Enzymology of HI V-I Reverse Transcriptase 
3.5.1 Effect of substrate concentration on HIV-l RT activity 
A plot of the initial velocity (Vo) against the substrate concentration for HIV -1 RT 
showed that an increased reaction rate occurred as a function of the dTTP concentration. 
This rate reached a maximum at 0.25 mM dTTP (Figure 3.10). Further addition of dTTP 
resulted in a gradual decrease in the rate of cDNA synthesis. Inhibition of HIV -1 RT was 
most likely due to substrate inhibition and not Mg2+ depletion, since the Mg2+ 
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Figure 3.10: Initial rate (Vo) for the formation of cDNA as a function of the dTTP concentration. 
The assay was carried out in the presence of 5.0 mM MgCI2 . The data represent the mean (± SO) of two 
replicate samples. 
The kinetic parameters of the reaction were estimated using a model that accounts for 
data that exhibit substrate inhibition (Cleland, 1979). It is based on the assumption 
(Verhamme et aI., 1988) that an ineffective (dead end) enzyme substrate complex with 
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The rate equation (b) is derived from the reaction scheme (a) above. 
v 
(b) 
The data for the initial rate of cDNA formation as a function of dTTP fitted well when n 
was assigned a value of 2, suggesting that the model reasonably described the kinetics of 
HIV -1 RT as the concentration of dTTP increased. The superscript "n" represented the 
total number of substrate molecules bound to an ineffective complex. Since two substrate 




The K m, Ki and V max were estimated to be 0.097 ± 0.004 mM, 10.82 ± 1.20 mM and 
0.223 ± 0.004 ~M/min respectively. The data were further analysed using a Hill plot to 
assess if the binding of the first dTTP molecule to HIV-RT had an effect on the binding 
of the second molecule. A Hill coefficient of one was obtained at low dTTP 
concentration and less than one at high dTTP concentration, suggesting zero and negative 
cooperativity respectively (Michel, 2007). 
Failure by HIV -1 RT to obey Michaelis - Menten kinetics has been reported previously 
(Furman et aI., 1991). These authors used a recombinant HIV -1 RT to incorporate dTTP 
into a poly (rA).oligo(dTJO) complex. Substrate inhibition was reported to occur at 
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3.5.2 Effect of 3,4,5 tri-O-galloylq uinic acid on HIV -1 RT activity 
Since 3,4,5 tri-O-galloylquinic acid inhibited M-MLV RT activity, an assay was 
performed to assess whether a similar inhibition was observed with HIV -1 RT. The 
concentrations of 3,4,5 tri-O-galloylquinic acid used were up to 82 11M. The results 
showed an exponential response of HIV -1 RT inhibition in this concentration range 
(Figure 3.11) and the IC so was estimated to be 34 11M. A similar IC so value for 
3,4,5 tri-O-galloylquinic acid inhibition of HIV -1 RT has been reported previously using 
an enzyme activity assay based on the incorporation of radio-labeled eH] dTMP into 
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Figure 3.11: Inhibition of HIV-l RT activity as a function of 3,4,5 tri-O-galloylquinic acid 
concentration. 
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3.5.3 Mode of 3,4,5 tri-O-galloylquinic acid binding to HIV-l RT 
The nature of HIV -1 RT inhibition by 3,4,5 tri-O-galloylquinic acid was investigated 
by assaying HIV -1 RT activity in the presence and absence of 34 /lM 
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Figure 3.12: Lineweaver-Burk plot of dTTP incorporation into poly (rA).oligo(dT)25 by HlV-1 RT in 
the presence (_) and absence (0) of 34 /lM 3,4,5 tri-O-galloylquinic acid. 
The data represent the mean (± SO) of two replicate samples. 
A Lineweaver-Burke plot (Figure 3.12) showed an apparent change in the values of both 
the Km and V max in the presence of 3,4,5 tri-O-galloylquinic acid. This suggested 
mixed non-competitive inhibition. This type of inhibition demonstrated that 
3,4,5 tri-O-galloylquinic acid bound HIV -1 RT at a site other than the active site, and also 
that its binding influenced the binding of dTTP. It has been reported that 
non-nucleoside HIV-1 RT inhibitors (NNRTI's) such as Nevirapine, Efivarenz and 
Delaviridine, bind to the same hydrophobic pocket that is located between the ~-sheets 
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(Kohlstaedt et aI., 1992, Pata et aI., 2004). It is possible that 3,4,5 tri-O-galloylquinic acid 
binds to this same NNRTI hydrophobic pocket. Mixed non-competitive inhibition has, 
however, been reported to occur if the binding sites for both substrate and inhibitor are in 
close proximity or if the binding of inhibitor induces a conformational change in the 
enzyme which affects substrate binding (Garrett and Grisham, 2005). Inhibition constants 
for mixed non-competitive inhibition are not the same, i.e. K/j t- K j In the case of 
inhibition of HIV -1 RT by 3,4,5 tri-O-galloylquinic acid, the value of K/j was less than 
that of K j suggesting that binding of 3,4,5 tri-O-galloylquinic acid to the enzyme 
substrate complex (ES) was stronger than to the free enzyme (E). Kinetic parameters for 
dTTP incorporation into poly (rA).0Iigo(dT25) complex by HIV-l RT in the absence and 
presence of 3,4,5 tri-O-galloylquinic acid are summarized in Table 3.5. The V max and Km 
values observed were similar to those estimated previously (Figure 3.10) 
Table 3.5: Kinetic parameters for dTTP incorporation into poly (rA) : oligo (dThs complex using 
HIV-J RT in the presence and absence of 3,4,5 tri-O-galloylquinic acid. 
Reaction velocity units represent the concentration of base pairs incorporated per minute 
Parameter No TGQ added TGQ added 
Vmax (j.!M/min) 0.169 ± 0.002 
I 
V max (j.!M/min) 0.072 ± 0.004 
Km (mM) 0.13 ± 0.03 
Kim (mM) 0.07 ± 0.01 
K, (j.!M) 135 ± 89 
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3.5.4 Reversibility of 3,4,5 tri-O-galloylquinic acid binding to HIV-l RT 
The reversibility of 3,4,5 tri-O-galloylquinic acid binding to M-MLV RT was 
determined by performing an enzyme activity assay in the presence of 100 IlM 
3,4,5 tri-O-galloylquinic acid and 11.0 IlM BSA. The BSA molar concentration was 
sufficient to bind all the 3,4,5 tri-O-galloylquinic acid present (Kawamoto et aI, 1995). 
The molar ratio of BSA to HIV-l RT was 63:1. The Mg2+ concentration was 5.0 mM. 
The results showed that HIV-l RT activity in the presence of BSA alone 
was similar to that in its absence (Figure 3.13), showing that BSA did not inhibit 
HIV-l RT activity. The activity of the enzyme in the presence of3,4,5 tri-O-galloylquinic 
acid alone was approximately 5 %. BSA addition subsequent to 3,4,5 tri-O-galloylquinic 
acid addition restored the activity of HIV -1 RT to 53 %. Similarly, HIV -1 RT addition 
subsequent to BSA and 3,4,5 tri-O-galloylquinic acid addition resulted in an 
activity of 63 %, clearly showing that the binding of 3,4,5 tri-O-galloylquinic acid 
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Figure 3.13: Effect of BSA on HIV-l RT activity in the absence and presence of 100 /lM 
3,4,5 tri-O-galloylquinic acid 
The enzyme activity was performed as follows: (A) no addition; (B) BSA; (C) 100 11M 
3,4,5 tri-O-galloylquinic acid; (D) HIV -I RT + 3,4,5 tri-O-galloylquinic acid, then BSA; 
(E) BSA + 3,4,5 tri-O-galloylquinic acid, then HIV-I RT. The data represent the mean (±SO) of duplicate 
samples 
3.5.5 Effect of Nevirapine on HIV-l RT 
The effect of Nevirapine on HIV-I RT activity was next investigated. The results showed 
that addition of Nevirapine to the RT assay at 1 ~M caused double the inhibition 
observed at 100 nM (Table 3.6), but that the higher concentration was insufficient to 
reduce the activity by 50 %. No effect was observed for DMSO alone used as a control. 
Although the median 50 % inhibitory concentration for Nevirapine has been reported to 
be 100 nM (Merluzzi et aI., 1990), this study was performed using aRT from a different 
HIV strain. Since Nevirapine has been reported to interact with Tyr 181 and Tyr 188 
residues in the inhibitor binding pocket of HIV-RT through aromatic ring stacking, any 
mutation at either of these two residues would result in reduced Nevirapine binding. 
Moreover, a wide range of single point mutations in HIV -1 RT has been associated with 
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Inhibition (%) 
14 ± 2 
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3.6 A comparison of the catalytic efficiencies of M-MLV RT and HIV-l RT and 
their response to 3,4,5 tri-O-galloylquinic acid 
3.6.1 Catalytic efficiencies 
The kinetic parameters for the two RTs were compared (Table 3.7). Since the 
concentrations ofM-MLVand HIV-I RT used were 0.071 /lM and 0.17 /lM respectively, 
V max could not be used to compare the efficiencies since it is dependent on the initial 
enzyme concentration. Kcat and Km, however, are independent of the initial enzyme 
concentration, and so can be used to compare catalytic efficiencies. 
Kcat (the turnover number or molecular activity) is the number of substrate molecules 
converted into product per enzyme molecule per unit time under saturating substrate 
conditions. The kinetic efficiency of a given enzyme is directly proportional to the 
turnover number (Garrett and Grisham, 2005). The turnover number of M-MLV RT was 
approximately 10 times higher than that of HIV-I RT (Table 3.7). Kcat has been reported 
to be physiologically irrelevant, because substrates rarely attain saturating concentrations 
in vivo. The kinetic efficiency under physiological conditions is therefore given by an 
apparent second order rate constant, KcaJKm (Garrett and Grisham, 2005), which was 
similar for both enzymes. These findings demonstrated that M-MLV RT was kinetically 
more efficient than HIV -I RT under saturating substrate concentrations, and equally 
efficient under limiting substrate concentrations. Km is the concentration of the substrate 
that results in the velocity of an enzymatic reaction equal to half its maximum velocity, 
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and enzyme (Garrett and Grisham, 200S). Results showed stronger binding of dTTP to 
HIV-I RT than to M-ML V RT. 
Table 3.7: Kinetic parameters for cDNA synthesis by M-MLV and HIV-l RTs. 
The Km value is an average of Km values from two independent experiments 
Parameter Enzyme 
M-MLV RT HIV-l RT 
V max (M/min) 0.8 ± 0.2 X 10.6 0.22 ± 0.004 X 10.6 
Kcat (min·') 11 ± 3 1.31 ± 0.02 
Km(M) 0.98 ± 0.14 X 10.3 0.11 ± O.OIS x 10-3 
Kcat/Km (min·'M·') 1.1 ± 0.3 x 104 1.2 ± 0.2 x 104 
3.6.2 Response to 3,4,5 tri-O-galloylquinic acid 
The dose response curves for HIV -I RT and M-ML V RT activity as a function of the 
3,4,S tri-O-galloylquinic acid concentration are compared in Figure 3.14. Both enzymes 
showed decreased catalytic activity in the presence of 3,4,S tri-O-galloylquinic acid. The 
ICso values were O.S J.!M and 34 J.!M for M-MLV RT and for HIV-I RT respectively, this 
occurring at molar ratios of 3,4,S tri-O-galloylquinic acid:M-MLV RT and 3,4,S tri-O-
galloylquinic acid:HIV-I RT of 7:1 and 200:1 respectively. This was a clear indication 
that M-MLV RT was very much more sensitive to 3,4,S tri-O-galloylquinic acid than 
HIV-I RT. 3,4,S Tri-O-galloylquinic acid inhibited M-MLV and HIV-I RT activities by 











Chapter 3 Enzymology of Reverse Transcriptase 
M-ML V R T, mixed non-competitive inhibition was observed for HIV -1 R T. 
3,4,5 Tri-O-galloylquinic acid binding to M-MLV RT was irreversible, which suggested 
strong interactions. Weak interactions, however, existed between 3,4,5 tri-O-
galloylquinic acid and HIV-l RT as the activity of the enzyme was partially restored on 


















-3.5 -4.5 -5.5 -6.5 -7.5 
Log [TGQ] M 













A quick, reliable non-radioactive reverse transcriptase assay was developed. This was 
used to confirm the previous finding that the HIV-l RT enzyme displayed 
substrate inhibition (Furman et ai., 1991). This assay was also used to confirm 
the IC50 for 3,4,5 tri-O-galloylquinic acid inhibition of HI V-I RT (Nishizawa et ai., 1988) 
as well as Nevirapine specificity for HIV-l RT inhibition 
(Merluzzi et ai., 1990; Smerdon et ai., 1994). 
Although the M-MLV and HIV-l RT enzymes belong to the same family, they differ in 
their responses to treatment with inhibitors. Thus 3,4,5 tri-O-galloylquinic acid 
non-competitively inhibited M-ML V R T whereas mixed inhibition was observed for 
HIV-l RT under similar conditions. The IC50 values for 3,4,5 tri-O-galloylquinic acid 
were also different, with M-MLV RT being more sensitive to this compound than 
HIV -1 R T. Care therefore needs to be taken in postulating the kinetic behaviour of a 
given RT enzyme since it may not be representative of the RT family. 
The data regarding HIV-l RT inhibition by 3,4,5 tri-O-galloylquinic acid suggested that 
it would be highly unlikely that oral administration of this polyphenol would act as an 
effective inhibitor of HIV reverse transcriptase for the following reasons: 
1. The relatively high concentration (IC50= 34 11M) of 3,4,5 tri-O-galloylquinic acid 
required to inhibit the HIV RT would necessitate ingestion of large quantities of 












glycosylated polyphenols are absorbed into the blood stream 
(Conquer et aI., 1997, Neuhouser, 2004) . 
2. The competitive and non specific binding of 3,4,5 tri-O-galloylquinic acid to 
other proteins such as serum albumin would reduce the effective concentration of 
this polyphenol in the blood stream. 
3. The 3,4,5 tri-O-galloylquinic acid concentration inside the appropriate immune 
cell would most likely be substantially lower than that in the blood stream due to 
transport constraints. 
However, preliminary results have shown that 3,4,5 tri-O-galloylquinic acid reduces the 
viral count in tissue culture experiments (Brandt, unpublished results). It would appear 
this polyphenol reduces the entry of HIV -I into CD-4 cells. This could be due to the 
binding of 3,4,5 tri-O-galloylquinic acid to the viral coat proteins or to interacting with 
the cell membrane and/or membrane proteins. This may explain why healthy nutrition 
and the incorporation of fruits and vegetables into the diet lowers the HIV viral count in 
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